Journals / Çocuk Dergisi / 2005 / Cilt: 5 - Sayı: 3

Diseases according to C-reactive protein

C-reaktif proteine göre hastalıklar

Pages
205–210
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: CRP can be used for determination of the diagnosis, prognosis of disease and response to the treatment with serial measurements.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: C-reactive protein (CRP) is used for rapid diagnosis and prognosis of the diseases.
📊
Key Findings & Data:Methods: The study was designed as prospectively and performed on 534 patients within a period of 12 months.
💡
Conclusion & Impact:Conclusion: CRP can be used for determination of the diagnosis, prognosis of disease and response to the treatment with serial measurements.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İleriye dönük çalışma · C-reaktif protein · Çocuk

Abstract

Aim: C-reactive protein (CRP) is used for rapid diagnosis and prognosis of the diseases. We wanted to determine the CRP values of patients in our clinic whose illnesses were clearly diagnosed. Methods: The study was designed as prospectively and performed on 534 patients within a period of 12 months. Results: There were 261 (48.9%) and 273 (51.1%) patients with infectious and non-infectious origin, respectively. It was determined that CRP values were 29.1 (bacterial 39.3, viral 6.4) mg/L in those with infectious origin and 3.7 mg/L in non-infectious origin. There was statistically significant difference between infectious and non-infectious disease groups (p<0.05). Of those with infectious origin there was statistically significant difference between bacterial and viral causes (p<0.05). Conclusion: CRP can be used for determination of the diagnosis, prognosis of disease and response to the treatment with serial measurements.

Özet

Amaç: C-reaktif protein (CRP) hastalıkların hızlı tanı ve prognozunu belirlemede kullanılmaktadır. Kliniğimizde tanısı kesin olarak konulmuş hastalarımızdaki CRP değerlerini tespit etmek istedik. Yöntem: Çalışma prospektif olarak 12 aylık sürede ve toplam 534 hastada yapıldı. Bulgular: Infeksiyöz nedenli 261 (% 48.9) ve infeksiyöz olmayan nedenli 273 (% 51.1) vaka vardı. Infeksiyöz nedenlilerde CRP değeri 29.1 (bakteriyel 39.3, viral 6.4) mg/L ve infeksiyöz olmayan nedenlilerde 3.7 mg/L olarak saptandı. Infeksiyöz nedenliler ile infeksiyöz olmayan nedenliler arasında istatistiksel fark vardı (p<0.05). Infeksiyöz nedenlilerden bakteriyel ve viral etkenler arasında da istatistiksel fark saptandı (p<0.05). Sonuç: CRP tanıyı desteklemek, seri ölçümlerle hastalığın seyrini ve tedaviye cevabı belirlemek için kullanılabilir.

🔖

Cite This Article

AKARSU, S., AYDIN, M., YILMAZ, E., KURT, A., POYRAZOĞLU, H. G., KURT, Ç. A. N. (2005). Diseases according to C-reactive protein. Çocuk Dergisi, Cilt: 5 - Sayı: 3, 205–210. https://ajindex.com/articles/189561

References (21)

  1. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004
  2. 48487-90. 2.Szalai AJ. The biological functions of C-reactive protein. Vas-cul Pharmacol 2002
  3. Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med 1999
  4. Mortensen RF, Zhong W. Regulation of phagocytic leukocyte activities by C.-reactive protein. J Leukoc Biol 2000
  5. de Maat MP, Trion A. C-reactive protein as a risk factor versus risk marker. Curr O pin Lipidol 2004
  6. Zimmerman MA, Selzman CH, Cothren C, et al. Diagnostic implications of C-reactive protein. Arch Surg 2003
  7. Mahmoud FA, Rivera NI. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 2002
  8. Rosalki SB. C-reactive protein. Int J Clin Pract 2001
  9. Dupuy AM, Terrier N, SenecaJ L, et al, Is C-reactive protein a marker of inflammation? Nephrologie 20Ö3
  10. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J.Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004
  11. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004
  12. Hansen JG, Dahler-Eriksen BS. C-reactive protein and infections in general practice. Ugeskr Laeger 2000
  13. Yeh ET. CRP as a mediator of disease. Circulation 2004
  14. Mary R, Veinberg F, Couderc R. Acute meningitidis, acute phase proteins and procalcitonin. Ann Biol Clin (Paris) 2003
  15. Tibbie JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001
  16. Rollino C, Boero R, Ferro M, et al. Acute pyelonephritis: analysis of 52 cases. Ren Fail 2002
  17. Nascimento MM, Pecoits-Filho R, Qureshi AR, et al. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant 2004
  18. Hengst JM. The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care 2003
  19. Kawczynski P, Piotrowski A. Prokalcitonin and C-reactive protein as a markers of neonatal sepsis. Ginekol Pol 2004
  20. Korppi M. Community-acquired pneumonia in children: issues in optimizing antibacterial treatment. Paediatr Drugs 2003
  21. Ito K, Yoshiyama T, Wa